GlaxoSmithKline Pakistan Limited (PSX: GLAXO)
174.25
+10.87 (6.65%)
At close: Sep 9, 2024
GlaxoSmithKline Pakistan Company Description
GlaxoSmithKline Pakistan Limited operates as a biopharma company in Pakistan and internationally.
It deals in anti-infective, dermatology, respiratory, analgesics, immunology, oncology, urology, HIV, vaccines, and analgesics therapy areas.
The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Cutivate, Calpol, Boostrix, Rotarix, Havrix, and Synflorix.
The company was founded in 2001 and is headquartered in Karachi, Pakistan. GlaxoSmithKline Pakistan Limited is a subsidiary of GSK plc.
GlaxoSmithKline Pakistan Limited
Country | Pakistan |
Founded | 2001 |
Industry | Pharmaceuticals |
Sector | Healthcare |
Employees | 1,700 |
CEO | Erum Rahim |
Contact Details
Address: 35, Dockyard Road Karachi, 74000 Pakistan | |
Phone | 92 21 111 475 725 |
Website | pk.gsk.com |
Stock Details
Ticker Symbol | GLAXO |
Exchange | Pakistan Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | PKR |
ISIN Number | PK0001301016 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Erum Rahim | Chief Executive Officer |
Hasham Baber | Chief Financial Officer |